Related Experiment Video
Updated: May 27, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Pleiotropic effects of pitavastatin
1Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montréal (IRCM) and University of Montréal, QC, Canada. Jean.Davignon@ircm.qc.ca
British Journal of Clinical Pharmacology
|November 8, 2011
Summary
Pitavastatin, a statin, offers cardiovascular benefits beyond lowering LDL cholesterol. Its pleiotropic effects improve endothelial function, reduce inflammation, and combat oxidative stress, contributing to better cardiovascular health.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins (HMG-CoA reductase inhibitors) are primary treatments for hypercholesterolaemia.
- Pleiotropic (cholesterol-independent) effects of statins contribute to cardiovascular benefits.
- Pitavastatin possesses unique properties among statins, suggesting distinct pleiotropic actions.
Purpose of the Study:
- To review the pleiotropic effects of pitavastatin.
- To examine pitavastatin's impact on endothelial function, vascular inflammation, oxidative stress, and thrombosis.
Main Methods:
- Systematic literature search (December 2010) with recent updates.
- Inclusion of clinical trials, in vitro, and animal studies.
Main Results:
- Pitavastatin reduces LDL cholesterol and triglycerides.
- Increases HDL cholesterol and decreases platelet activation markers.
- Improves cardiac, renal, and endothelial function; reduces oxidative stress and atherosclerosis signs.
Conclusions:
- Pitavastatin exhibits diverse pleiotropic effects.
- These actions may reduce cardiovascular morbidity and mortality beyond LDL-C reduction.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...